- Home
- DRCT vs ADIL Comparison
DRCT vs ADIL Comparison
Compare DRCT & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- ADIL
- Stock Information
- Founded
- DRCT 2018
- ADIL 2010
- Country
- DRCT United States
- ADIL United States
- Employees
- DRCT N/A
- ADIL N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- ADIL Health Care
- Exchange
- DRCT Nasdaq
- ADIL Nasdaq
- Market Cap
- DRCT 8.8M
- ADIL 7.7M
- IPO Year
- DRCT 2022
- ADIL 2018
- Fundamental
- Price
- DRCT $0.35
- ADIL $0.38
- Analyst Decision
- DRCT Strong Buy
- ADIL Strong Buy
- Analyst Count
- DRCT 1
- ADIL 2
- Target Price
- DRCT $6.00
- ADIL $4.75
- AVG Volume (30 Days)
- DRCT 5.5M
- ADIL 733.6K
- Earning Date
- DRCT 11-07-2025
- ADIL 11-12-2025
- Dividend Yield
- DRCT N/A
- ADIL N/A
- EPS Growth
- DRCT N/A
- ADIL N/A
- EPS
- DRCT N/A
- ADIL N/A
- Revenue
- DRCT $36,459,000.00
- ADIL N/A
- Revenue This Year
- DRCT $16.81
- ADIL N/A
- Revenue Next Year
- DRCT $35.28
- ADIL N/A
- P/E Ratio
- DRCT N/A
- ADIL N/A
- Revenue Growth
- DRCT N/A
- ADIL N/A
- 52 Week Low
- DRCT $0.28
- ADIL $0.22
- 52 Week High
- DRCT $6.59
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- DRCT 48.96
- ADIL 53.47
- Support Level
- DRCT $0.33
- ADIL $0.35
- Resistance Level
- DRCT $0.37
- ADIL $0.39
- Average True Range (ATR)
- DRCT 0.05
- ADIL 0.03
- MACD
- DRCT 0.00
- ADIL -0.00
- Stochastic Oscillator
- DRCT 26.61
- ADIL 41.56
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.